Cipla Generic Asthma Drug

Cipla shares surge 8.6% on launch of its generic asthma drug

New Delhi: Shares of Cipla Ltd surged as much as 8.6% to hit a record high of Rs 575.20 apiece after it launched its generic drug used for treatment of asthma and chronic obstructive pulmonary